The role of eNOS gene polymorphisms on contrast induced nephropathy development in chronic kidney disease patients

被引:0
|
作者
Kilic, Ilhan [1 ]
Palabiyik, Orkide [2 ]
Kurultak, Ilhan [3 ]
Sipahi, Tammam [2 ]
Ustundag, Sedat [3 ]
机构
[1] Edirne Sultan 1 Murat State Hosp, Nephrol Dept, Fatih St, TR-22030 Edirne, Turkey
[2] Trakya Univ, Biophys Dept, Edirne, Turkey
[3] Trakya Univ, Nephrol Dept, Edirne, Turkey
关键词
chronic kidney disease; contrast nephropathy; gene polymorphism; NITRIC-OXIDE PRODUCTION; PATHOGENESIS; ASSOCIATION; PROTEINS;
D O I
10.1111/1744-9987.13921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Contrast nephropathy is a result of contrast media given through intravascular routes. Nitric oxide gene polymorphisms may alter the hemodynamic stability resulting in medullary ischemia Nitric oxide gene polymorphisms may have an enhancing role in contrast media related renal injury. The aim of this study was to investigate the role of eNOS intron 4a/b, T786C, and G894T gene polymorphisms on contrast-nephropathy risk. Methods Ninety-four chronic kidney disease patients with contrast nephropathy and 120 chronic kidney disease patients without contrast nephropathy were included. DNA isolation was performed and specific regions of DNA for eNOS G894T, T786C, and intron 4a/b genes were amplified by polymerase chain reaction technique. Results TT polymorphism of T786C gene and GG polymorphism of G894T gene were detected to be possibly protective from contrast induced nephropathy. Conclusion Endothelial nitric oxide synthase G894T gene polymorphisms, older age, and presence of diabetes mellitus may influence contrast nephropathy development.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 50 条
  • [21] Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients
    Osugi, Naohiro
    Suzuki, Susumu
    Shibata, Yohei
    Tatami, Yosuke
    Harata, Shingo
    Ota, Tomoyuki
    Hayashi, Mutsuharu
    Yasuda, Yoshinari
    Ishii, Hideki
    Shimizu, Atsuya
    Murohara, Toyoaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (03) : 391 - 397
  • [22] Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy
    Athyros, Vasilios G.
    Tziomalos, Konstantinos
    Karagiannis, Asterios
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (09) : 1059 - 1066
  • [23] Intravenous album in for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT
    Choi, Heejung
    Kim, Yoonjung
    Kim, Soo Min
    Shin, Junam
    Jang, Hye Ryoun
    Lee, Jung Eun
    Huh, Wooseong
    Kim, Yoon-Goo
    Oh, Ha Young
    Kim, Dae Joong
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2012, 31 (02) : 106 - 111
  • [24] Matrix Metalloproteinase-9 Gene Polymorphisms and Chronic Kidney Disease
    Okada, Rieko
    Kawai, Sayo
    Naito, Mariko
    Hishida, Asahi
    Hamajima, Nobuyuki
    Shinchi, Koichi
    Turin, Tanvir Chowdhury
    Suzuki, Sadao
    Mantjoro, Eva Mariane
    Toyomura, Kengo
    Arisawa, Kokichi
    Kuriyama, Nagato
    Hosono, Satoyo
    Mikami, Haruo
    Kubo, Michiaki
    Tanaka, Hideo
    Wakai, Kenji
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (05) : 444 - 450
  • [25] Reduction in the risk of contrast-induced nephropathy using enhanced external counter-pulsation in patients with chronic kidney disease
    Zeng, Chun-Mei
    Pan, Hong-Yu
    Zhao, Yan-Mei
    Ling, Zheng
    Liu, Ming
    Feng, Ying
    RENAL FAILURE, 2024, 46 (02)
  • [26] The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial
    Kyungil Park
    Woo-Young Chung
    Jae-Bin Seo
    Sang-Hyun Kim
    Joo-Hee Zo
    Myung-A Kim
    Young-Bae Park
    Trials, 11
  • [27] Understanding the role of genetic polymorphisms in chronic kidney disease
    Karin Luttropp
    Peter Stenvinkel
    Juan Jesús Carrero
    Roberto Pecoits-Filho
    Bengt Lindholm
    Louise Nordfors
    Pediatric Nephrology, 2008, 23 : 1941 - 1949
  • [28] Understanding the role of genetic polymorphisms in chronic kidney disease
    Luttropp, Karin
    Stenvinkel, Peter
    Carrero, Juan Jesus
    Pecoits-Filho, Roberto
    Lindholm, Bengt
    Nordfors, Louise
    PEDIATRIC NEPHROLOGY, 2008, 23 (11) : 1941 - 1949
  • [29] Effects of Carperitide on Contrast-Induced Acute Kidney Injury with a Minimum Volume of Contrast in Chronic Kidney Disease Patients
    Okumura, Naoki
    Hayashi, Mutsuharu
    Imai, Enyu
    Ishii, Hideki
    Yoshikawa, Daiji
    Yasuda, Yoshinari
    Goto, Motomitsu
    Matsuo, Seiichi
    Oiso, Yutaka
    Murohara, Toyoaki
    NEPHRON EXTRA, 2012, 2 (01): : 303 - 310
  • [30] Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients
    Issar, Tushar
    Arnold, Ria
    Kwai, Natalie C. G.
    Walker, Susan
    Yan, Aimy
    Borire, Adeniyi A.
    Poynten, Ann M.
    Pussell, Bruce A.
    Endre, Zoltan H.
    Kiernan, Matthew C.
    Krishnan, Arun, V
    CLINICAL NEUROPHYSIOLOGY, 2019, 130 (11) : 2088 - 2095